These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach. Makatini MM; Petzold K; Sriharsha SN; Ndlovu N; Soliman ME; Honarparvar B; Parboosing R; Naidoo A; Arvidsson PI; Sayed Y; Govender P; Maguire GE; Kruger HG; Govender T Eur J Med Chem; 2011 Sep; 46(9):3976-85. PubMed ID: 21741133 [TBL] [Abstract][Full Text] [Related]
7. Linear and cyclic glycopeptide as HIV protease inhibitors. Pawar SA; Jabgunde AM; Maguire GE; Kruger HG; Sayed Y; Soliman ME; Dhavale DD; Govender T Eur J Med Chem; 2013 Feb; 60():144-54. PubMed ID: 23291117 [TBL] [Abstract][Full Text] [Related]
8. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study. Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668 [TBL] [Abstract][Full Text] [Related]
9. Exploring the drug resistance mechanism of active site, non-active site mutations and their cooperative effects in CRF01_AE HIV-1 protease: molecular dynamics simulations and free energy calculations. C S V; Tamizhselvi R; Munusami P J Biomol Struct Dyn; 2019 Jul; 37(10):2608-2626. PubMed ID: 30051758 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Nine Compounds Isolated from the Acid Hydrolysate of Wang X; Wei Y; Tian WY; Sakharkar MK; Liu Q; Yang X; Zhou YZ; Mou CL; Cai GL; Yang J Molecules; 2019 Dec; 24(24):. PubMed ID: 31835661 [TBL] [Abstract][Full Text] [Related]
11. Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease. Kempf DJ Methods Enzymol; 1994; 241():334-54. PubMed ID: 7854187 [No Abstract] [Full Text] [Related]
12. Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study. Honarparvar B; Pawar SA; Alves CN; Lameira J; Maguire GE; Silva JR; Govender T; Kruger HG J Biomed Sci; 2015 Feb; 22(1):15. PubMed ID: 25889635 [TBL] [Abstract][Full Text] [Related]
13. Ionization state of the catalytic dyad Asp25/25' in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis. Torbeev VY; Kent SB Org Biomol Chem; 2012 Aug; 10(30):5887-91. PubMed ID: 22659831 [TBL] [Abstract][Full Text] [Related]
14. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic. Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353 [TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics and ligand docking of a hinge region variant of South African HIV-1 subtype C protease. Zondagh J; Balakrishnan V; Achilonu I; Dirr HW; Sayed Y J Mol Graph Model; 2018 Jun; 82():1-11. PubMed ID: 29625416 [TBL] [Abstract][Full Text] [Related]
16. Design of tight-binding human immunodeficiency virus type 1 protease inhibitors. Vacca JP Methods Enzymol; 1994; 241():311-34. PubMed ID: 7854186 [No Abstract] [Full Text] [Related]
17. The active site of HIV-1 protease. Mager PP Med Res Rev; 2001 Jul; 21(4):348-53. PubMed ID: 11410934 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123 [TBL] [Abstract][Full Text] [Related]
19. Insights into effect of the Asp25/Asp25' protonation states on binding of inhibitors Amprenavir and MKP97 to HIV-1 protease using molecular dynamics simulations and MM-GBSA calculations. Yu YX; Wang W; Sun HB; Zhang LL; Wu SL; Liu WT SAR QSAR Environ Res; 2021 Aug; 32(8):615-641. PubMed ID: 34157882 [TBL] [Abstract][Full Text] [Related]
20. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance. Naicker P; Achilonu I; Fanucchi S; Fernandes M; Ibrahim MA; Dirr HW; Soliman ME; Sayed Y J Biomol Struct Dyn; 2013 Dec; 31(12):1370-80. PubMed ID: 23140382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]